FDA Investigator Brenda W Uratani, PhD
Brenda W Uratani, PhD has conducted inspections on 23 sites in 7 countries as of 16 Jul 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
16 Jul 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Australia,
China,
United States of America,
Switzerland,
Canada,
United Kingdom of Great Britain and Northern Ireland,
Germany
FDA Investigators that have inspected at least one site in common with Brenda W Uratani, PhD:
Alan P Kurtzberg,
Amanda E Lewin, PhD,
Anastasia G Lolas,
Andrea A Branche,
Anh M Lac,
Anita Narula, PhD,
Ann L Demarco,
Anthony J Ladner,
Arsen Karapetyan,
Aurora Miha Trifanov,
Azza Talaat,
Barbara D Wright,
Barbara Janine Breithaupt,
Benjamin J Dastoli,
Binh T Nguyen,
Bo Chi, PhD,
Brooke K Higgins,
Camerson E Moore,
Candace Y Gomez Broughton,
Carl Lee,
Carla J Lundi,
Carrie A Hughes,
Charanjeet Jassal,
Charisse K Green,
Charles I Ann,
Charles R Cote, RIC,
Christopher Downey, PhD,
Christopher T Middendorf,
Claire M Minden,
Concepcion Cruz, Jr,
Diane L Raccasi,
Djamila Harouaka,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Dr. Gang Wang, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Dr. Zhihao Qiu (Peter), PhD,
Eileen A Liu,
Eliezar Ramos,
Ellen P Madigan,
Emest F Bizjak,
Eric L Dong, BS,
Eric M Mueller, PharmD,
Erika V Butler,
Felix Maldonado,
Frank W Perrella,
Gamal A Norton,
Gary J Lehr,
Gerard Pde Leon,
Ginger M Sykes,
Israel Santiago, OCM,
Ivan E Reyes,
Ivis L Negron,
Jacek Cieslak, PhD,
James A Jagon,
James K Ireland,
James S Stuart, BS,
Jeffrey P Raimondi,
Jen Sui,
Jennifer M Gogley,
John D White,
John S Hartford,
Jolanna A Norton,
Jonathan W Chapman,
Jose R Hernandez,
Julie D Bringger,
Kalavati Suvarna, PhD,
Karen M Cooper,
Katherine Szestypalow,
Kathleen R Jones, PhD,
Kathy Lee,
Kenneth H Williams,
Kevin A Gonzalez,
Kham Phommachanh,
Kim Lthomas Cruse,
Krishna Ghosh, PhD,
Kurt A Brorson, PhD,
L Norwood,
Laura Fontan, MS,
Laurie Graham,
LCDR Debra Emerson,
Lewis K Antwi,
Li Hongpaul Yeh, PhD,
Libia M Lugo,
Linda F Murphy,
Lloyd D Payne,
Lori A Holmquist,
M Pedgen,
Margaret M Annes,
Marie A Fadden,
Marie F Morin,
Marijo B Kambere, PhD,
Mariza M Jafary,
Mark Brunswick, PhD,
Mark R Mcclain,
Marlene G Swider,
Marvin D Jones,
Mary E Farbman, PhD,
Mary E Storch,
Mary Jeanet Mcgarry,
Matthew B Casale,
Matthew R Dionne,
Megan A Haggerty,
Metitia M Gramby,
Michael A Charles,
Michael E Maselli,
Michael Shanks, MS,
Michelle Yclark Stuart,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Mindy M Chou,
Monica Commerford, PhD,
Mra Davism,
Mra Munizn,
Neal L Adams,
Nicholas F Lyons,
Nicholas L Paulin,
Obinna R Echeozo,
Omotunde O Osunsanmi,
Pankaj H Amin,
Parul M Patel,
Patricia D Stahnke,
Patricia F Hughes, PhD,
Paul A Bonneau,
Paul L Bellamy,
Paul Mouris,
Pete Amin (Pankaj),
Peter C Chow,
Prabhu P Raju,
Priscilla M Pastrana,
Qing Joanna Zhou, PhD,
Ramon E Martinez,
Ranjani Prabhakara,
Rashmi Rawat, PhD,
Ravichandran Veerasamy, PhD,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Richard W Berning,
Robert C Steyert,
Robert D Tollefsen,
Robert J Martin,
Robert Jennings,
Roger F Zabinski,
Rose Ashley,
Russell K Riley,
Samina S Khan,
Scott R Nichols, PhD,
Sean R Marcsisin,
Sharon K Thoma, PharmD,
Stacey S Degarmo,
Stephen D Brown,
Steven Fong, MS, PhD,
Steven M Weinman,
Susan W Ting,
Svetlana A Shestopal,
Teresa I Navas,
Terri L Dodds,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Torrance J Slayton,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Valentino Fiorella,
Veronica Fuentes, MS,
Vijaya L Simhadri,
Vioela J Caze,
Virgilio F Pacio, CSO,
Walter N Lange,
Wayne E Seifert,
Xiaokuang Lai, PhD,
Xikui Chen (nmi), PhD,
Yanming An, PhD,
Yiying E Chen,
Yumi J Hiramine,
Zachary A Bogorad,
Zachary L Miller,
Zerita White,
Zhong Li, PhD,
Zi Qiang Gu,
Ziyang Su, PhD
Brenda W Uratani, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| August, 2012 | EIR | UNIVERSITY OF CALIFORNIA, LOS ANGELES - EIR, 2012-08-24 |
| May, 2008 | FDA 483 Response | SOFIE Co. dba SOFIE - Form 483R, 2008-06-04 |
| June, 2013 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2013-06-26 |
| January, 2009 | FDA 483 | FUJIFILM Diosynth Biotechnologies UK Ltd - Form 483, 2009-01-09 |
| March, 2002 | FDA 483 | Novez Pharma - Form 483, 2002-03-28 |
| July, 2013 | FDA 483 | University of Washington PET Radiochemistry Laboratory - Form 483, 2013-07-18 |
| March, 2011 | FDA 483 | Qingdao Jiulong Biopharmaceutical Co., Ltd. - Form 483, 2011-03-18 |
| August, 2012 | EIR | PETNET SOLUTIONS, INC. - EIR, 2012-08-29 |
| August, 2012 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2012-08-08 |
| May, 2008 | FDA 483 | SOFIE Co. dba SOFIE - Form 483, 2008-05-27 |
| September, 2012 | FDA 483 | Cardinal Health 414, LLC - Form 483, 2012-09-26 |
| May, 2013 | FDA 483 | The Feinstein Institutes for Medical Research - Form 483, 2013-05-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more